December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Fresenius Kabi

< Previous 1 2 3 Next >
News headline image
Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces KabiCare Nutrition Resources for U.S. Parenteral Nutrition Products
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Announces 2022 Inductees to Blood Donation Hall of Fame
From Fresenius Kabi
Via Business Wire
News headline image
Fort HealthCare Goes Live with Smart Pump Interoperability with the Ivenix Infusion System from Fresenius Kabi
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Injection, USP
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Selected to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from September 4-10, 2022
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi, a Leader in Injectable Medicines, Introduces Data Matrix Barcodes on all Drugs as part of Companywide Commitment to Medication Safety
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
From Fresenius Kabi
Via Business Wire
News headline image
Romidepsin for Injection Available from Fresenius Kabi
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Expands RFID Compatibility to Improve Hospital Inventory Management
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer
From Fresenius Kabi
Via Business Wire
News headline image
Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection in Ready-to-Administer freeflex® Bags
From Fresenius Kabi
Via Business Wire
News headline image
Blood Centers Across America Unite to Provide Blood Supplies to Ukraine
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces Copay Assistance for Cancer Treatments Using Generic Medicines
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Announces FDA Approval of SMOFlipid® Lipid Injectable Emulsion for Pediatric Patients Requiring Parenteral Nutrition
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Receives U.S. Food and Drug Administration 510(k) Clearance for Wireless Agilia® Connect Infusion System with Vigilant® Software Suite-Vigilant® Master Med Technology
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Announces 2021 Inductees to Blood Donation Hall of Fame
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi and Health Care Logistics, Inc. Collaborate on RFID Compatibility
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Introduces New Simplist® Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe
From Fresenius Kabi
Via Business Wire
News headline image
Fresenius Kabi Receives Premier Supplier Legacy Award
From Fresenius Kabi
Via Business Wire
News headline image
Temsirolimus Injection Now Available from Fresenius Kabi
From Fresenius Kabi
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.